Table 2.
Virus | Season | No. of samples | All sites | Catalytic sites | Non‐catalytic sites | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of total AA mutations | No. of total AAs | Mutation rate (%) | No. of total AA mutations | No. of total AAs | Mutation rate (%) | No. of total AA mutations | No. of total AAs | Mutation rate (%) | P value | |||
A/H1N1pdm09 | 2013‐2014 | 20 | 49 | 9380 | 0.52 | 2 | 380 | 0.53 | 47 | 9000 | 0.52 | 0.991 |
2015‐2016 | 20 | 42 | 9380 | 0.45 | 3 | 380 | 0.79 | 39 | 9000 | 0.43 | 0.308 | |
2016‐2017 | 9 | 14 | 4221 | 0.33 | 0 | 171 | 0.00 | 14 | 4050 | 0.35 | 0.441 | |
Total | 49 | 105 | 22 981 | 0.46 | 5 | 931 | 0.54 | 100 | 22 050 | 0.45 | 0.711 | |
A/H3N2 | 2011‐2012 | 48 | 120 | 22 512 | 0.53 | 3 | 912 | 0.33 | 117 | 21 600 | 0.54 | 0.387 |
2012‐2013 | 48 | 97 | 22 512 | 0.43 | 4 | 912 | 0.44 | 93 | 21 600 | 0.43 | 0.971 | |
2013‐2014 | 20 | 77 | 9380 | 0.82 | 1 | 380 | 0.26 | 76 | 9000 | 0.84 | 0.219 | |
2014‐2015 | 40 | 165 | 18 760 | 0.88 | 0 | 760 | 0.00 | 165 | 18 000 | 0.92 | 0.008 | |
2015‐2016 | 19 | 58 | 8911 | 0.65 | 1 | 361 | 0.28 | 57 | 8550 | 0.67 | 0.367 | |
2016‐2017 | 76 | 226 | 35 644 | 0.63 | 4 | 1444 | 0.28 | 222 | 34 200 | 0.65 | 0.081 | |
Total | 251 | 743 | 117 719 | 0.63 | 13 | 4769 | 0.27 | 730 | 112 950 | 0.65 | 0.001 | |
B | 2013‐2014 | 20 | 82 | 9320 | 0.88 | 0 | 380 | 0.00 | 82 | 8940 | 0.92 | 0.061 |
2014‐2015 | 19 | 41 | 8854 | 0.46 | 0 | 361 | 0.00 | 41 | 8493 | 0.48 | 0.186 | |
2015‐2016 | 20 | 29 | 9320 | 0.31 | 0 | 380 | 0.00 | 29 | 8940 | 0.32 | 0.266 | |
2016‐2017 | 21 | 98 | 9786 | 1.00 | 0 | 399 | 0.00 | 98 | 9387 | 1.04 | 0.040 | |
Total | 80 | 250 | 37 280 | 0.67 | 0 | 1520 | 0.00 | 250 | 35 760 | 0.70 | 0.001 |
AA, amino acid.
The neuraminidase AA lengths of A/H1N1pdm09, A/H3N2, and B viruses were 469, 469, and 466 AAs, respectively. The neuraminidase catalytic sites consisted of a total of 19 AAs.